Michael Mager of Precision Neuroscience, a brain implant startup rival to Elon Musk's Neuralink, sounds off on the future of ...

After becoming one of the president-elect’s most prominent backers on the campaign trail, many are wondering what is in it ...

Four years after winning an FDA approval for Koselugo to treat children with the rare disorder neurofibromatosis type 1 (NF1) ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

Neuralink, Elon Musk’s brain-computer venture, and rivals like Max Hodak’s Science, are chasing advances in technology that ...

Nevro's HFX iQ spinal cord stimulator earned the European Union's CE mark, the company said Nov. 12.

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

Discover how Remedy Logic's FDA-cleared RAI program, powered by AI, is revolutionizing spine MRI interpretation for radiologists and patients.

November is National Family Caregivers Month. Numbers from the National Council on Aging show that 53 million people are ...

SANTA FE, N.M., Nov. 13, 2024 /PRNewswire/ -- Vitazi.ai, a leader in the field of oculomics, is transforming healthcare with an innovative approach to early disease interception through point-of-care ...

Amicus Therapeutics’ first oral drug for the rare condition Fabry disease has been approved by the FDA, giving patients an alternative to conventional injected enzyme replacement therapy.

(IN BRIEF) Michael Schmid has been elected as the new President of Eurojust, taking office on 15 November 2024 for a ...